Polymyxin B-hemoperfusion in acute exacerbation of idiopathic pulmonary fibrosis: a feasibility step forward.
作者信息
Choi Won-Il
机构信息
Department of Internal Medicine, Myongji Hospital, Hanyang University College of Medicine, Goyang, Korea.
出版信息
Korean J Intern Med. 2025 May;40(3):345-346. doi: 10.3904/kjim.2025.111. Epub 2025 Apr 30.
Abstract
摘要
相似文献
1
Polymyxin B-hemoperfusion in acute exacerbation of idiopathic pulmonary fibrosis: a feasibility step forward.多粘菌素B血液灌流治疗特发性肺纤维化急性加重：向前迈出的可行性一步。
Korean J Intern Med. 2025 May;40(3):345-346. doi: 10.3904/kjim.2025.111. Epub 2025 Apr 30.
2
Direct hemoperfusion with polymyxin B-immobilized fiber for the treatment of the acute exacerbation of idiopathic pulmonary fibrosis in patients requiring invasive mechanical ventilation.使用多粘菌素B固定化纤维进行直接血液灌流治疗需要有创机械通气的特发性肺纤维化急性加重期患者。
Respir Investig. 2017 Sep;55(5):318-322. doi: 10.1016/j.resinv.2017.05.001. Epub 2017 Jul 3.
3
[Direct hemoperfusion with a polymyxin B-immobilized fiber column eliminates neutrophils and improves pulmonary oxygenation--a comparison of two cases with acute exacerbation of idiopathic pulmonary fibrosis].[用多黏菌素B固定化纤维柱直接血液灌流清除中性粒细胞并改善肺氧合——两例特发性肺纤维化急性加重病例的比较]
Nihon Kokyuki Gakkai Zasshi. 2007 Nov;45(11):890-7.
4
Direct hemoperfusion with polymyxin B immobilized fiber column (PMX) treatment for acute exacerbation of idiopathic pulmonary fibrosis: A prospective multicenter cohort study.用多粘菌素B固定化纤维柱（PMX）直接血液灌流治疗特发性肺纤维化急性加重：一项前瞻性多中心队列研究。
Respir Investig. 2025 Jan;63(1):102-108. doi: 10.1016/j.resinv.2024.11.017. Epub 2024 Dec 12.
5
Polymyxin B-hemoperfusion in patients with acute exacerbation of idiopathic pulmonary fibrosis: a single-center prospective pilot study.多黏菌素B血液灌流治疗特发性肺纤维化急性加重期患者：一项单中心前瞻性初步研究。
Korean J Intern Med. 2025 May;40(3):458-467. doi: 10.3904/kjim.2024.244. Epub 2025 Apr 30.
6
Improved Prognostic Prediction by Combination of Early Initiation of Polymyxin B Hemoperfusion with Modified Gender-Age-Physiology Index in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.在特发性肺纤维化急性加重期，联合应用早期多黏菌素 B 血液灌流与改良性别-年龄-生理指数可改善预后预测。
Blood Purif. 2022;51(6):485-491. doi: 10.1159/000518705. Epub 2021 Sep 9.
7
Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis.多黏菌素B固定化纤维柱（PMX）血液灌流治疗对特发性肺纤维化急性加重期的有益作用。
Intern Med. 2006;45(18):1033-8. doi: 10.2169/internalmedicine.45.6018. Epub 2006 Oct 16.
8
Association between cytokine removal by polymyxin B hemoperfusion and improved pulmonary oxygenation in patients with acute exacerbation of idiopathic pulmonary fibrosis.多黏菌素 B 血液灌流清除细胞因子与特发性肺纤维化急性加重患者肺氧合改善的关系。
Cytokine. 2013 Jan;61(1):84-9. doi: 10.1016/j.cyto.2012.08.032. Epub 2012 Sep 26.
9
Two cases of acute exacerbation of interstitial pneumonia treated with polymyxin B-immobilized fiber column hemoperfusion treatment.两例间质性肺炎急性加重期患者采用多粘菌素B固定化纤维柱血液灌流治疗。
Intern Med. 2007;46(17):1447-54. doi: 10.2169/internalmedicine.46.0117. Epub 2007 Sep 3.
10
Serum cytokine changes induced by direct hemoperfusion with polymyxin B-immobilized fiber in patients with acute respiratory failure.多黏菌素 B 免疫吸附纤维直接血液灌流治疗急性呼吸衰竭患者血清细胞因子的变化。
Respir Investig. 2022 Jul;60(4):585-594. doi: 10.1016/j.resinv.2022.04.003. Epub 2022 May 5.
本文引用的文献
1
Polymyxin B-hemoperfusion in patients with acute exacerbation of idiopathic pulmonary fibrosis: a single-center prospective pilot study.多黏菌素B血液灌流治疗特发性肺纤维化急性加重期患者：一项单中心前瞻性初步研究。
Korean J Intern Med. 2025 May;40(3):458-467. doi: 10.3904/kjim.2024.244. Epub 2025 Apr 30.
2
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化（更新版）和成人进展性肺纤维化：美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
3
Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial.环磷酰胺联合糖皮质激素治疗特发性肺纤维化急性加重（EXAFIP）：一项随机、双盲、安慰剂对照、3 期临床试验。
Lancet Respir Med. 2022 Jan;10(1):26-34. doi: 10.1016/S2213-2600(21)00354-4. Epub 2021 Sep 7.
4
The effects of direct hemoperfusion with polymyxin B-immobilized fiber in patients with acute exacerbation of interstitial lung disease.多粘菌素B固定化纤维直接血液灌流对间质性肺疾病急性加重患者的影响。
Acute Crit Care. 2021 May;36(2):126-132. doi: 10.4266/acc.2021.00073. Epub 2021 Apr 15.
5
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.特发性肺纤维化：诊断和管理的循证指南（美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会联合发布）
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824. doi: 10.1164/rccm.2009-040GL.
6
Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial.早期应用多粘菌素B血液灌流治疗腹部感染性休克：EUPHAS随机对照试验
JAMA. 2009 Jun 17;301(23):2445-52. doi: 10.1001/jama.2009.856.
7
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review.多粘菌素B固定化纤维柱在脓毒症中的有效性：一项系统评价
Crit Care. 2007;11(2):R47. doi: 10.1186/cc5780.
8
Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis.多黏菌素B固定化纤维柱（PMX）血液灌流治疗对特发性肺纤维化急性加重期的有益作用。
Intern Med. 2006;45(18):1033-8. doi: 10.2169/internalmedicine.45.6018. Epub 2006 Oct 16.
9
Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin).用于治疗脓毒症的体外内毒素清除：内毒素吸附柱（Toraymyxin）
Ther Apher Dial. 2003 Feb;7(1):108-14. doi: 10.1046/j.1526-0968.2003.00005.x.
Zotero 插件